• Thu. Feb 2nd, 2023

News Info India

Get the real story

Male Infertility and Traditional Chinese Medicine

Male infertility

Infertility is defined as the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse. While infertility and childlessness have traditionally been associated with women, men’s roles in infertility issues are becoming more widely recognized. 

According to recent statistics, infertility in married couples is caused equally by problems with the male spouse. While there is a dearth of national data on male reproductive health, experts claim that rising male infertility rates in the United States match a global trend of deteriorating sperm quality over the previous 40 years.

Male factor infertility can be defined as any condition in which the male partner has a negative impact on a couple’s ability to conceive. Idiopathic infertility accounts for 30 per cent of cases of male infertility (MI), which is a complex multifactorial condition. Male factor infertility is most usually defined as abnormal sperm concentration (oligospermia), reduced sperm motility (asthenospermia), or teratospermia (abnormal sperm morphology.) The evidence for the efficacy of empirical medications is currently insufficient. 

Traditional Chinese Medicine (TCM) has been advocated by Chinese herbal medicine experts as a way to regulate the hypothalamic-pituitary-testicular axis and improve the function of Sertoli cells and Leydig cells.” He adds, “ It is an ancient Chinese medical system that has evolved over thousands of years. TCM practitioners treat health problems with a variety of psychological and/or physical treatments (such as acupuncture and tai chi) as well as herbal items.

TCM has also been shown to reduce inflammation, prevent oxidative stress, decrease DNA fragmentation, and regulate germ cell proliferation and death. However, the evidence in favour of TCM is weak, and it should not be used for more than three to four months. Advances in assisted reproductive technology, including as intrauterine insemination, in vitro fertilisation (IVF), and even intracytoplasmic sperm injection, have transformed the treatment of MI (ICSI). The mechanical placement of a cleaned pellet of ejaculated sperm within the female uterus, beyond the cervix, at the time of ovulation is known as intrauterine insemination (IUI). 

Furthermore, IVF is a medical technique that entails ovarian stimulation, egg retrieval, laboratory fertilisation of the egg, and embryo transfer to the uterus. Intracytoplasmic sperm injection, a laboratory supplement to IVF, was first documented in 1992. (ICSI). Individual sperm are drawn into a minuscule pipette by suction after the sperm tail is crushed to immobilise it. The sperm is injected into the unfertilised egg directly through the egg shell (zona pellucida), through the (perivitelline) region that separates the egg from the shell, and into the egg itself. ICSI reduced the number of moving sperm required for egg fertilisation from hundreds of thousands to a single living sperm, compared to IVF, which required hundreds of thousands of moving sperm for each egg. 

This method allows for the use of “immature” sperm retrieved surgically or by aspiration from men who have no sperm in their ejaculate. Sperm derived from the vas deferens, epididymis, and testicle are currently acceptable sources of sperm for use with ICSI.

Leave a Reply

Your email address will not be published. Required fields are marked *